News
BrainStorm Cell Therapeutics Inc. shares crashed 42.74% to $0.67 in after-hours trading on Friday after the company announced ...
GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...
FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the ...
Cover Media US on MSN33m
Low Doses of CBD Could Harm Liver, New FDA Study ShowsA new clinical trial raises concerns about the safety of low doses of cannabidiol (CBD), even as CBD products continue to grow in popularity.
CBD American Shaman and other purveyors of Gas Station Heroin have marketed 7 and Pseudo products as supplements formulated ...
Sarepta Therapeutics Inc. said another patient has died from acute liver failure after receiving one of its gene therapies, ...
Explore more
The agency says Juul's benefits as a less harmful alternative for adult smokers outweigh the risks of teen use. It's a major ...
The HHS secretary and four of his advisers earned at least $3.2 million from their work opposing Big Pharma and promoting ...
GSK shares fell more than 6% on Friday to the bottom of Britain's blue-chip index after a U.S. FDA advisory panel recommended ...
Our medical establishment told people to "Stop Trusting the Public Health Establishment". Now, almost no one trusts our ...
The Food and Drug Administration is allowing vaping brand Juul to keep its e-cigarettes on the market, providing relief to a company that has struggled for years after being widely blamed for sparking ...
GSK shares fell more than 6% on Friday after a U.S. FDA advisory panel recommended against approving its blood cancer drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results